Fortrea Welcomes William Sharbaugh to Leadership Team
Fortrea Strengthens Its Board with New Appointment
Recently, Fortrea, a prominent global contract research organization (CRO), has taken a significant step in enhancing its leadership team by appointing William Sharbaugh to its Board of Directors. With over three decades of experience in the pharmaceutical industry, Mr. Sharbaugh is expected to bring a wealth of knowledge and expertise to the board.
Valuable Experience in Healthcare
William Sharbaugh possesses extensive healthcare experience that encompasses finance, operations, and quality management. His previous roles in executive and board positions highlight his profound grasp of the complexities involved in the healthcare sector. His addition to the board is not just a strategic move; it reflects Fortrea's commitment to leveraging exceptional talent for driving growth and innovation.
Leadership Acknowledgment
Anshul Thakral, the CEO of Fortrea, shared his thoughts on the appointment, expressing his delight at welcoming someone with an impressive background in both CRO and pharmaceutical operations. According to Thakral, Sharbaugh's respected leadership aligns perfectly with Fortrea’s mission of delivering high-quality drug development solutions on a global scale. This partnership symbolizes Fortrea's dedication to producing life-changing treatments and pushing the boundaries of healthcare innovation.
A Look at Mr. Sharbaugh's Background
Before joining Fortrea, Mr. Sharbaugh held crucial positions that demonstrated his capabilities in steering organizations toward success in the highly competitive pharmaceutical landscape. Most notably, he served as the chairman of the board of Ora LLC, an ophthalmic research organization, and has held board positions at Launch Therapeutics, Inc., showcasing his versatility and influence within the industry.
Previous Leadership Roles
In addition to his notable roles, Mr. Sharbaugh has a history of impactful contributions to organizations like PPD, Inc., where he served as chief operating officer, and Bristol-Myers Squibb in a global development operations capacity. His solid foundation in clinical supply operations was further solidified during his decade of service at Merck & Co., contributing significantly to his holistic understanding of the pharmaceutical ecosystem.
Sharbaugh's Vision for Fortrea
As he steps into this new role, Mr. Sharbaugh has expressed enthusiasm for contributing to Fortrea’s vision moving forward. He aims to utilize his extensive experience to provide practical insights that will help shape the board's approach to future challenges and opportunities. His commitment to creating value for all stakeholders embodies the collaborative spirit that Fortrea fosters among its leadership team.
About Fortrea
Fortrea is recognized as a leading provider of clinical development solutions tailored to meet the unique needs of the life sciences industry. The organization partners with biopharmaceutical and biotechnology companies to accelerate the introduction of innovative therapies to patients globally. With a strong focus on clinical trial management and consulting services, Fortrea boasts three decades of expertise that spans over 20 therapeutic areas.
Strategic Focus on Healthcare Innovation
The company is dedicated to advancing healthcare solutions, boasting a talented workforce operating in approximately 100 countries. Fortrea's strategic approach and exceptional insights aim to transform its clients' visions into reality, making it a vibrant player in the industry.
Contact Information for Fortrea
For investors or media inquiries, Fortrea has designated contacts to facilitate communication. Tracy Krumme (Investors) can be reached at 984-385-6707 or via email at Tracy.Krumme@fortrea.com. For media inquiries, Sue Zaranek is available at 919-943-5422 and can be contacted through media@fortrea.com. Additionally, Kate Dillon is reachable at 646-818-9115.
Frequently Asked Questions
Who is William Sharbaugh?
William Sharbaugh is the newly appointed board member for Fortrea, with extensive experience in the pharmaceutical industry.
What is Fortrea's main focus?
Fortrea focuses on providing clinical development solutions, partnering with biopharmaceutical and biotechnology companies to accelerate healthcare innovation.
How will Sharbaugh contribute to Fortrea?
Sharbaugh will bring his extensive industry insight and practical perspectives to the board, helping to guide Fortrea's strategic direction.
What background does Sharbaugh have?
Sharbaugh has served in various executive positions in leading pharmaceutical companies and has significant experience in CRO operations.
How can media reach Fortrea?
Media representatives can contact Sue Zaranek at 919-943-5422 or email media@fortrea.com for inquiries.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.